These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 8573380)

  • 1. Investigation of proviral load in individuals infected with human T-lymphotropic virus type II.
    Woods TC; Graber JM; Hershow RC; Khabbaz RF; Kaplan JE; Heneine W
    AIDS Res Hum Retroviruses; 1995 Oct; 11(10):1235-9. PubMed ID: 8573380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of HTLV type I and HIV type I DNA load in coinfected patients: HIV type 1 infection does not alter HTLV type I proviral amount in the peripheral blood compartment.
    Césaire R; Dehée A; Lézin A; Désiré N; Bourdonné O; Dantin F; Béra O; Smadja D; Abel S; Cabié A; Sobesky G; Nicolas JC
    AIDS Res Hum Retroviruses; 2001 Jun; 17(9):799-805. PubMed ID: 11429121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low DNA HTLV-2 proviral load among women in São Paulo City.
    Montanheiro P; Olah I; Fukumori LM; Smid J; Oliveira AC; Kanzaki LI; Fonseca LA; Duarte AJ; Casseb J
    Virus Res; 2008 Jul; 135(1):22-5. PubMed ID: 18343520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitation of HTLV-I and II proviral load using real-time quantitative PCR with SYBR Green chemistry.
    Lee TH; Chafets DM; Busch MP; Murphy EL
    J Clin Virol; 2004 Dec; 31(4):275-82. PubMed ID: 15494269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between human T lymphotropic virus (HTLV) type 1/2 viral burden and clinical and treatment parameters among patients with HIV type 1 and HTLV-1/2 coinfection.
    Beilke MA; Traina-Dorge VL; Sirois M; Bhuiyan A; Murphy EL; Walls JM; Fagan R; Winsor EL; Kissinger PJ
    Clin Infect Dis; 2007 May; 44(9):1229-34. PubMed ID: 17407044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo fluctuation of HTLV-I and HTLV-II proviral load in patients receiving antiretroviral drugs.
    Machuca A; Soriano V
    J Acquir Immune Defic Syndr; 2000 Jun; 24(2):189-93. PubMed ID: 10935697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular tropism of human T-cell leukemia virus type II is enlarged to B lymphocytes in patients with high proviral load.
    Casoli C; Cimarelli A; Bertazzoni U
    Virology; 1995 Feb; 206(2):1126-8. PubMed ID: 7531916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HTLV-II down-regulates HIV-1 replication in IL-2-stimulated primary PBMC of coinfected individuals through expression of MIP-1alpha.
    Casoli C; Vicenzi E; Cimarelli A; Magnani G; Ciancianaini P; Cattaneo E; Dall'Aglio P; Poli G; Bertazzoni U
    Blood; 2000 May; 95(9):2760-9. PubMed ID: 10779418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coinfection with HIV-1 and human T-Cell lymphotropic virus type II in intravenous drug users is associated with delayed progression to AIDS.
    Turci M; Pilotti E; Ronzi P; Magnani G; Boschini A; Parisi SG; Zipeto D; Lisa A; Casoli C; Bertazzoni U
    J Acquir Immune Defic Syndr; 2006 Jan; 41(1):100-6. PubMed ID: 16340481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of HTLV-II proviral copies by competitive polymerase chain reaction in peripheral blood mononuclear cells of Italian injecting drug users, central Africans, and Amerindians.
    Cimarelli A; Duclos CA; Gessain A; Cattaneo E; Casoli C; Biglione M; Mauclère P; Bertazzoni U
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Oct; 10(2):198-204. PubMed ID: 7552486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Droplet digital PCR for absolute quantification of proviral load of human T-cell lymphotropic virus (HTLV) types 1 and 2.
    Thulin Hedberg S; Eriksson L; Demontis MA; Mölling P; Sundqvist M; Taylor G; Malm K; Andersson S
    J Virol Methods; 2018 Oct; 260():70-74. PubMed ID: 30006102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomere Length, Proviral Load and Neurologic Impairment in HTLV-1 and HTLV-2-Infected Subjects.
    Usadi B; Bruhn R; Lin J; Lee TH; Blackburn E; Murphy EL
    Viruses; 2016 Aug; 8(8):. PubMed ID: 27529270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transient increment of HTLV-2 proviral load in HIV-1-co-infected patients during treatment intensification with raltegravir.
    Abad-Fernández M; Cabrera C; García E; Vallejo A
    J Clin Virol; 2014 Mar; 59(3):204-7. PubMed ID: 24457115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human T lymphotropic virus types I and II western blot seroindeterminate status and its association with exposure to prototype HTLV-I.
    Yao K; Hisada M; Maloney E; Yamano Y; Hanchard B; Wilks R; Rios M; Jacobson S
    J Infect Dis; 2006 Feb; 193(3):427-37. PubMed ID: 16388491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo cellular tropism of human T-lymphotropic virus type II is not restricted to CD8+ cells.
    Lal RB; Owen SM; Rudolph DL; Dawson C; Prince H
    Virology; 1995 Jul; 210(2):441-7. PubMed ID: 7542419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of human T cell lymphotropic virus type 2 coinfection on virological and immunological parameters in HIV type 1-infected patients.
    Bassani S; López M; Toro C; Jiménez V; Sempere JM; Soriano V; Benito JM
    Clin Infect Dis; 2007 Jan; 44(1):105-10. PubMed ID: 17143825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High levels of CC-chemokine expression and downregulated levels of CCR5 during HIV-1/HTLV-1 and HIV-1/HTLV-2 coinfections.
    Oo Z; Barrios CS; Castillo L; Beilke MA
    J Med Virol; 2015 May; 87(5):790-7. PubMed ID: 25678365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of HTLV-II proviral sequences in HIV-immunosuppressed patients with HTLV indeterminate serological patterns.
    Soriano V; Gutiérrez M; González-Lahoz J
    J Infect; 1998 Mar; 36(2):243-4. PubMed ID: 9570669
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term variations in human T lymphotropic virus (HTLV)-I and HTLV-II proviral loads and association with clinical data.
    Kwaan N; Lee TH; Chafets DM; Nass C; Newman B; Smith J; Garratty G; Murphy EL;
    J Infect Dis; 2006 Dec; 194(11):1557-64. PubMed ID: 17083040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased human T-lymphotropic virus type II proviral load following highly active retroviral therapy in HIV-coinfected patients.
    Murphy EL; Grant RM; Kropp J; Oliveira A; Lee TH; Busch MP
    J Acquir Immune Defic Syndr; 2003 Aug; 33(5):655-6. PubMed ID: 12902815
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.